Ovid Therapeutics (OVID) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.17
-0.13
-0.1
-0.06

Details

Expected EPS
-0.1499
Actual EPS
-0.17
Surprise EPS
-0.02
Surprise Percent
+13.41%

Description

Ovid Therapeutics (OVID) has reported earnings of -0.17 per share for Q4 2025.

0 Comments

Share your thoughts